Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1997-10-14
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0028-2766
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
76
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
373-91
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9274834-Amyloidosis,
pubmed-meshheading:9274834-Deoxyglucose,
pubmed-meshheading:9274834-Glycosylation End Products, Advanced,
pubmed-meshheading:9274834-Humans,
pubmed-meshheading:9274834-Kidney Failure, Chronic,
pubmed-meshheading:9274834-Renal Dialysis,
pubmed-meshheading:9274834-beta 2-Microglobulin
|
pubmed:year |
1997
|
pubmed:articleTitle |
Beta2-Microglobulin dialysis amyloid and its formation: role of 3-deoxyglucosone and advanced glycation end products.
|
pubmed:publicationType |
Editorial,
Review
|